Related Experiment Video
Updated: Jan 18, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
AI-Powered Diabetes Precision Health: From Data to Action
Jia Nie1,2, Carol Haft1, Ashley Xia1
1Division of Diabetes, Endocrinology, and Metabolic Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Artificial intelligence (AI) offers significant potential for advancing Diabetes Precision Health. Experts discussed opportunities and challenges to personalize diabetes care through AI.
Area of Science:
- Endocrinology and Metabolism
- Artificial Intelligence in Healthcare
- Public Health
Background:
- Diabetes is a chronic, prevalent public health challenge requiring personalized management.
- The heterogeneity of diabetes necessitates tailored approaches for prevention, diagnosis, treatment, and prognosis.
Purpose of the Study:
- To describe opportunities and challenges in AI for Diabetes Precision Health.
- To outline strategies for advancing AI in personalized diabetes care.
Main Methods:
- Convened experts from diabetes and AI fields.
- Identified existing gaps and transformative opportunities enabled by AI advancements.
Main Results:
- Artificial intelligence holds considerable potential for Diabetes Precision Health.
- Key themes included the need for greater attention to AI in personalized diabetes care.
Conclusions:
- AI integration is crucial for advancing personalized diabetes management.
- Strategic planning is recommended to overcome challenges and leverage AI opportunities in diabetes care.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Psychoneuroimmunology: Diabetes and Cancer
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

